Royalty Pharma plans largest IPO of the year so far

Royalty Pharma is planning the biggest IPO of the year as the market’s appetite for biotech stocks remains strong.

The company said in a filing with the US financial regulator that it plans to raise up to $1.96 billion on the Nasdaq using the ticker RPRX.